Literature DB >> 17530625

Comments on 'Current issues in non-inferiority trials' by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855.

Gary G Koch1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 17530625     DOI： 10.1002/sim.2923

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  5 in total

1.  Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

Authors:  Marc D Schwartz; Heiddis B Valdimarsdottir; Beth N Peshkin; Jeanne Mandelblatt; Rachel Nusbaum; An-Tsun Huang; Yaojen Chang; Kristi Graves; Claudine Isaacs; Marie Wood; Wendy McKinnon; Judy Garber; Shelley McCormick; Anita Y Kinney; George Luta; Sarah Kelleher; Kara-Grace Leventhal; Patti Vegella; Angie Tong; Lesley King
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

2.  Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.

Authors:  Julio Rosenstock; Dale Allison; Andreas L Birkenfeld; Thalia Marie Blicher; Srikanth Deenadayalan; Jacob Bonde Jacobsen; Pierre Serusclat; Rafael Violante; Hirotaka Watada; Melanie Davies
Journal:  JAMA       Date:  2019-04-16       Impact factor: 56.272

3.  Efficacy of the unified protocol for the treatment of emotional disorders in the Spanish public mental health system using a group format: study protocol for a multicenter, randomized, non-inferiority controlled trial.

Authors:  Jorge Osma; Carlos Suso-Ribera; Azucena García-Palacios; Elena Crespo-Delgado; Cristina Robert-Flor; Ana Sánchez-Guerrero; Vanesa Ferreres-Galan; Luisa Pérez-Ayerra; Amparo Malea-Fernández; Mª Ángeles Torres-Alfosea
Journal:  Health Qual Life Outcomes       Date:  2018-03-12       Impact factor: 3.186

4.  Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.

Authors:  Mary K Interrante; Hannah Segal; Beth N Peshkin; Heiddis B Valdimarsdottir; Rachel Nusbaum; Morgan Similuk; Tiffani DeMarco; Gillian Hooker; Kristi Graves; Claudine Isaacs; Marie Wood; Wendy McKinnon; Judy Garber; Shelley McCormick; Jessica Heinzmann; Anita Y Kinney; Marc D Schwartz
Journal:  JNCI Cancer Spectr       Date:  2017-09-22

5.  Determining the sample size required to establish whether a medical device is non-inferior to an external benchmark.

Authors:  Adrian Sayers; Michael J Crowther; Andrew Judge; Michael R Whitehouse; Ashley W Blom
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.